Exagen (XGN) Cash from Investing Activities (2018 - 2026)
Exagen (XGN) reported Cash from Investing Activities of -$228000.0 for Q1 2026, down 113.08% on a YoY basis from $1.7 million in Q1 2025, and down 551.43% quarter-over-quarter from -$35000.0 in Q4 2025.
Exagen (XGN) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Exagen has reported Cash from Investing Activities for 9 years, with the latest figure at -$228000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 113.08% year-over-year to -$228000.0; the trailing twelve-month figure through Mar 2026 stood at -$747000.0 (down 39.37% YoY), and the FY2025 full-year result was -$626000.0, down 21.55% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$228000.0, down from -$35000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$2000.0 in Q3 2023, with the low at -$1.9 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$381823.5 across 5 years, with a median of -$209000.0 in 2025.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 99.77% — and 2024, when it slumped 7250.0%.
- Exagen's Cash from Investing Activities stood at -$406000.0 in 2022, then soared by 79.31% to -$84000.0 in 2023, then sank by 73.81% to -$146000.0 in 2024, then jumped by 76.03% to -$35000.0 in 2025, then tumbled by 551.43% to -$228000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$228000.0 (Q1 2026), -$35000.0 (Q4 2025), and -$275000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -196.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -32.14 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Exagen | 100.67 Mn | 79.16 Mn | 10.21 Mn | -228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -228,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | -275,000.00 |
| Sep 30, 2025 | -275,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Mar 31, 2025 | -107,000.00 |
| Mar 31, 2025 | -107,000.00 |
| Dec 31, 2024 | -146,000.00 |
| Dec 31, 2024 | -146,000.00 |
| Sep 30, 2024 | -147,000.00 |
| Sep 30, 2024 | -147,000.00 |
| Jun 30, 2024 | -136,000.00 |
| Jun 30, 2024 | -136,000.00 |
| Mar 31, 2024 | -86,000.00 |
| Mar 31, 2024 | -86,000.00 |
| Dec 31, 2023 | -84,000.00 |
| Dec 31, 2023 | -84,000.00 |